Co-creating New Innovations
PharmExec
JANUARY 11, 2023
Pharma companies are teaming with academic institutions earlier in the R&D process.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
PharmExec
JANUARY 11, 2023
Pharma companies are teaming with academic institutions earlier in the R&D process.
European Pharmaceutical Review
NOVEMBER 14, 2023
Ajinomoto Co., Impact of the acquisition agreement Timothy Miller, PhD, CEO, President, and Co-founder of Forge Biologics stated that the CDMO is “excited” to join Ajinomoto Co. The post New acquisition to support global gene therapy manufacturing appeared first on European Pharmaceutical Review.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
DECEMBER 21, 2023
Piramal Pharma Solutions has officially opened new facilities at its antibody-drug conjugate (ADC) manufacturing facility in Grangemouth, Scotland. We see the market gravitating towards large and commercial scale manufacturing, which the new facility is well equipped to address,” he added.
Eversana Intouch
NOVEMBER 16, 2023
Last week, Frontiers Health, the premier global digital health innovation event, was held in Rome, Italy. With sessions focused on the themes of digital health, therapeutics, and innovation, EVERSANA subject matter experts were featured speakers alongside our new Healthware colleagues across eight sessions.
Pharmaceutical Technology
MARCH 21, 2023
InvisiShield Technologies’ president, chief scientific officer and co-founder Dr Warner Greene said: “We are excited to be collaborating with Gladstone to develop intranasal preventatives for three of the most significant respiratory viral infections, SARS-CoV-2, influenza and RSV.
European Pharmaceutical Review
MAY 26, 2023
Steve Bates OBE, CEO of the Bioindustry Association welcomed the initiatives, “including those that will improve access to finance for start-ups and scale-ups, and to create a pro-innovation regulatory environment. The post Life sciences sector to receive £650 million funding appeared first on European Pharmaceutical Review.
World of DTC Marketing
AUGUST 12, 2022
PhRMA is lying to protect its profits, and the lies have reached a new height as the Senate moved to adopt modest drug pricing negotiation measures in the Inflation Reduction Act. Of course, the drug industry warns that any price negotiation will kill innovation. This is, of course, pure b t. In 2021 alone, the top U.S.
European Pharmaceutical Review
JULY 6, 2023
Could BioNTech’s new partnership accelerate personalised mRNA therapy trials? Deemed a “landmark new agreement” by UK Prime Minister Rishi Sunak, the UK-based clinical trials will focus on personalised mRNA-based cancer immunotherapies.
Pharmaceutical Technology
OCTOBER 25, 2022
Under the joint research project, a new research team will be set up at the BioMed X Institute in Heidelberg, Germany. This team will focus on creating a versatile computational platform that can precisely forecast the first-in-class drug candidates’ efficacy in virtual patient groups.
European Pharmaceutical Review
DECEMBER 2, 2022
A new facility will be built on the site premises, doubling the capacity for biologics manufacturing at the facility. It is anticipated a further 400-500 roles will be created, bringing the total Pfizer employees in Ireland to around 5,500. The firm’s manufacturing sites in Grange Castle, Newbridge, Co. Pfizer Inc.
World of DTC Marketing
NOVEMBER 9, 2021
The objective was to identify new and preferred pathways for the creation and delivery of medical information. Key Finding 3: The wheels are now in motion with digital innovation, but pharma is far from full speed ahead. Innovation has been hampered by a fundamental lack of internal capacity coupled with a time lag for reorganization.
Pharmaceutical Technology
MAY 19, 2023
ImmunoForge will expedite the development of new drugs based on the elastin-like polypeptide (ELP) platform technology originally developed by Duke’s Professor Ashutosh Chilkoti. Duke University will use the ELP platform technology to develop new anticancer drugs and share the profits of commercialisation with ImmunoForge.
Clarivate
AUGUST 16, 2023
Ed has developed new methods of analyzing innovation ecosystems and advised hundreds of corporations, institutions and governments with technology data investigations. Today, Ed continues to look for new ways to help innovators, strategists and IP professionals use patent data to make more informed decisions.
European Pharmaceutical Review
AUGUST 17, 2022
Contract research, development and manufacturing organisation (CRDMO) WuXi STA has broken ground on its new 190-acre pharmaceutical manufacturing campus in Middletown, Delaware, US. This campus is only possible because of Delaware’s world-class, innovative workforce. WuXi STA has 12 sites across the US, Europe and Asia.
PM360
MARCH 24, 2023
Considering the recent focus on mental health, this felt very relevant and made sense for a conference focusing on innovation to look at all aspects of innovation, including disease treatment. Founded by Brian O’Kelley, who was an early innovator in the programmatic space, Scope3 has emerged as a leader in sustainability.
Pharmaceutical Technology
FEBRUARY 21, 2023
The new company will mainly use Teijin Group’s core healthcare company, Teijin Pharma’s drug discovery research capabilities, facilities, personnel, technologies, and equipment. The two companies aim to conclude a final agreement within the fiscal year ending in March next year and then set up a new company shortly.
Clarify Health
FEBRUARY 6, 2023
New York, NY (February 6, 2023) – Clarify Health , a leading healthcare analytics platform company, is proud to be named to the New York Digital Health 100 (DH100) for the third consecutive year. The annual list highlights the most exciting and innovative startups in the New York region. “We
PM360
NOVEMBER 16, 2023
Unlike other generative AI tools, which only generate new content, Genome Perspective was created to understand content and advance it in a practical way. We saw these groundhog-day tasks as prime candidates for AI-based automation,” said Klick Co-Founder Aaron Goldstein.
European Pharmaceutical Review
AUGUST 23, 2022
based process (HTA) that will allow the competent EU and national authorities to determine the effectiveness of new or existing health technologies (eg, medicinal products, medical devices, in vitro diagnostic medical devices, medical procedures and measures to prevent, diagnose or treat diseases). It introduces an evidence?based
Pharmaceutical Technology
MAY 15, 2023
Cu is a new diagnostic radioisotope that provides distinct properties for safe, cost-effective and enhanced diagnostics to improve cancer-staging and ensuing treatment decisions. It expects to help patients living with a range of solid tumours with new diagnostic and therapeutic treatments.
PM360
JANUARY 5, 2024
The Omega collaboration will leverage its proprietary platform technology to develop an epigenomic controller designed to enhance metabolic activity as a part of a potential new treatment approach for obesity management. Novo Nordisk is committed to advancing new treatment options for people living with cardio-metabolic diseases.
pharmaphorum
DECEMBER 21, 2022
The sector is built on a holistic and innovative mindset. That’s why Accenture and the World Economic Forum created a ‘ Sustainability DNA ‘ model – a route for how the sector can keep pace with its sustainability objectives. Innovation – using technology to solve problems without creating harmful side-effects.
PM360
JULY 18, 2022
SPAG, which serves global biopharma companies, health trade associations, and health provider systems, is also one of the most awarded agencies in the region having been named Global New PR Agency in 2015, Asia-Pacific Healthcare Agency of Year (2017 & 2019) at Sabre awards, and Large Agency of the Year in 2021 & 2022 by E4M (IPRCCA).
Pharmaceutical Technology
DECEMBER 19, 2022
This consists of any projects that have expanded the company’s footprint in the sector, including: contract wins; launching in new territories; launching new product lines; the acquisition and expansion of facilities and real estate; acquisition of new machinery or other assets; improved logistics; partnerships; and significant staff increases.
Pharmaceutical Technology
JANUARY 11, 2023
Under the collaboration, the two companies established a joint AI Innovation Lab to apply for advances in AI and ML technology to develop new therapies for different cancers and infectious diseases. BioNTech stated that the deal builds on a multi-year strategic collaboration between the companies, announced in November 2020.
Impetus Digital
SEPTEMBER 21, 2022
Dr. Luca Dezzani , VP of US Oncology Medical Affairs at Johnson & Johnson , will join Natalie Yeadon , Co-founder & CEO of Impetus Digital , for a discussion around innovation in Medical Affairs, new technologies for data dissemination and medical education, how to engage with different healthcare stakeholders, plus much more.
pharmaphorum
OCTOBER 12, 2022
David Del Bourgo (CEO and co-founder, Whitelab Genomics) has always been passionate about introducing disruptive, innovative technologies to markets. In 2019, Del Bourgo and co-founder Julien Cottineau launched Whitelab Genomics and its AI platform dedicated to supporting the discovery and design of genomic therapies.
European Pharmaceutical Review
OCTOBER 11, 2022
Data will identify the CO? emissions created during travel, the sources of energy used and what consumables were employed throughout the clinical development process. The analysis is intended to help companies reduce the impact their research has on the environment.
European Pharmaceutical Review
OCTOBER 24, 2022
A new UK research consortium will lead the way in overcoming the monkeypox pandemic with £2 million of funding from The Biotechnology and Biosciences Research Council (BBSRC) and the Medical Research Council (MRC), both part of UK Research and Innovation (UKRI).
Pharmaceutical Technology
NOVEMBER 9, 2022
It intends to pursue new targets and the discovery of biomarkers, starting with a rare cancer indication that is undisclosed. The platform overcomes the limitations of traditional techniques by creating a resilient replica of host tumour environments.
PM360
AUGUST 24, 2023
GOATs create new paths and then run down them. Meta knew it was easy to clone Twitter and everyone knew everyone wanted a new text app. Zuck brought his 2B+ customers to his new app. Savvy marketers create value for brands when they focus on strategy and understand precisely when to employ AI and other tools.”
pharmaphorum
OCTOBER 27, 2022
Having recognised the tangible benefits that their unique insights and experiences can bring to the table, decision-makers are increasingly seeking new opportunities to partner with patients across a product’s lifecycle. Co-creating a patient engagement impact framework.
Contrarian Sales Techniques
NOVEMBER 5, 2023
The difference between stagnant sales and exponential growth can often be traced back to a company’s willingness to adapt and innovate in its sales strategy. At the heart of their success was a decision to leverage cutting-edge technology to redefine their customer engagement and product innovation strategies. The result?
Pharmaceutical Technology
FEBRUARY 2, 2023
The University of Texas MD Anderson Cancer Center has announced a strategic collaboration with Federation Bio for the development of a new microbiome treatment for immunotherapy-resistant cancer patients.
Pharmaceutical Technology
AUGUST 11, 2022
GentiBio and Bristol Myers Squibb (BMS) have signed a multi-year partnership agreement for developing new engineered Treg therapies for inflammatory bowel disease (IBD) patients. We are excited to collaborate with GentiBio as we explore creating potentially promising Tregs for patients suffering from IBD.”.
European Pharmaceutical Review
JUNE 27, 2023
For World Microbiome Day on 27 June 2023, EPR put questions to Hervé Affagard, CEO and co-founder of MaaT Pharma and Jeffrey Silber, Chief Medical Officer of Vedanta Biosciences, to find out how the field is progressing and what innovations could transform future microbiome-based therapies.
pharmaphorum
DECEMBER 20, 2022
The problem is not a lack of innovation. The goal is to create a new framework for improving patient access to molecularly guided treatments under South Korea’s National Health Insurance, supported by real-world evidence.
Impetus Digital
DECEMBER 7, 2022
A broad range of backgrounds and skill sets through diverse hiring allows organizations to be more innovative, better understand a wider array of consumer segments, and ultimately be more successful. Cecilia helped co-found the DEI committee with Amelia. ” “A diverse workplace is important because it breeds innovation.
European Pharmaceutical Review
APRIL 11, 2024
Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available. However, changing long-standing and proven approaches to new product development across a whole sector is no small task. 1 That’s more than the automotive sector, which released 46.4
pharmaphorum
JANUARY 25, 2023
The 501(c)3 non-profit Tidepool, which seeks to empower the next generation of innovations in diabetes management, has announced that the US Food and Drug Administration (FDA) has cleared Tidepool Loop, an automated insulin dosing app intended for the management of type 1 diabetes (T1D) in those six years old and above. and Harry B.
Vodori
JUNE 17, 2022
This is a co-authored blog post between Vodori and Marimac Insight, a scientific management consulting company. Considering a new medical, legal, regulatory review software solution at your pharma or device company is a big undertaking. Create buy-in for a new system up-front. Understand medical affairs’ requirements.
PM360
JULY 12, 2023
. “We are very excited to have Fern Lazar join the Board of Trustees at the Cancer Research Institute,” said board Co-Chairman, Andrew Tsai. “Fern is an early pioneer in the biotech communications field and understands the importance of validating and communicating innovations in health, like the power of immunotherapy.
pharmaphorum
NOVEMBER 25, 2022
With over 40% of all medicines in the pipeline aimed at rare diseases, and around 50 new therapies approved around the world each year, the future looks positive for increasing the number of treatments available. This approach gave a weak basis for population data and thus created a high level of uncertainty in the model outputs.
PM360
JUNE 26, 2023
Firstly, entering new markets and increasing sales should boost revenue. This can be especially important in the current global economic climate, where competition for market share is fierce, and access to new customers is critical for growth. In a shareholder meeting, Merck & Co.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content